| PDB code | Main view | Title | | 1a85 |  | Mmp8 with malonic and asparagine based inhibitor |
| 1a86 |  | Mmp8 with malonic and aspartic acid based inhibitor |
| 1af0 |  | Serratia protease in complex with inhibitor |
| 1akl |  | Alkaline protease from pseudomonas aeruginosa ifo3080 |
| 1ast |  | Structure of astacin and implications for activation of astacins and zinc-ligation of collagenases |
| 1ayk |  | Inhibitor-free catalytic fragment of human fibroblast collagenase, nmr, 30 structures |
| 1b3d |  | Stromelysin-1 |
| 1b8y |  | X-ray structure of human stromelysin catalytic domain complexed with non-peptide inhibitors: implications for inhibitor selectivity |
| 1biw |  | Design and synthesis of conformationally-constrained mmp inhibitors |
| 1bm6 |  | Solution structure of the catalytic domain of human stromelysin-1 complexed to a potent non-peptidic inhibitor, nmr, 20 structures |
| 1bqo |  | Discovery of potent, achiral matrix metalloproteinase inhibitors |
| 1bqq |  | Crystal structure of the mt1-mmp--timp-2 complex |
| 1buv |  | Crystal structure of the mt1-mmp-timp-2 complex |
| 1bzs |  | Crystal structure of mmp8 complexed with hmr2909 |
| 1c3i |  | Human stromelysin-1 catalytic domain complexed with ro-26- |
| 1c8t |  | Human stromelysin-1 (e202q) catalytic domain complexed with ro-26-2812 |
| 1caq |  | X-ray structure of human stromelysin catalytic domain complexes with non-peptide inhibitors: implication for inhibitor selectivity |
| 1cge |  | Crystal structures of recombinant 19-kda human fibroblast collagenase complexed to itself |
| 1cgf |  | Crystal structures of recombinant 19-kda human fibroblast collagenase complexed to itself |
| 1cgl |  | Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor |
| 1ciz |  | X-ray structure of human stromelysin catalytic domain complexes with non-peptide inhibitors: implication for inhibitor selectivity |
| 1ck7 |  | Gelatinase a (full-length) |
| 1cqr |  | Crystal structure of the stromelysin catalytic domain at 2.0 a resolution |
| 1cxv |  | Structure of recombinant mouse collagenase-3 (mmp-13) |
| 1d5j |  | Crystal structure of mmp3 complexed with a thiazepine based inhibitor. |
| 1d7x |  | Crystal structure of mmp3 complexed with a modified proline scaffold based inhibitor. |
| 1d8f |  | Crystal structure of mmp3 complexed with a piperazine based inhibitor. |
| 1d8m |  | Crystal structure of mmp3 complexed with a heterocycle- based inhibitor |
| 1eak |  | Catalytic domain of prommp-2 e404q mutant |
| 1eub |  | Solution structure of the catalytic domain of human collagenase-3 (mmp-13) complexed to a potent non-peptidic sulfonamide inhibitor |
| 1fbl |  | Structure of full-length porcine synovial collagenase (mmp1) reveals a c-terminal domain containing a calcium- linked, four-bladed beta-propeller |
| 1fls |  | Solution structure of the catalytic fragment of human collagenase-3 (mmp-13) complexed with a hydroxamic acid inhibitor |
| 1fm1 |  | Solution structure of the catalytic fragment of human collagenase-3 (mmp-13) complexed with a hydroxamic acid inhibitor |
| 1g05 |  | Heterocycle-based mmp inhibitor with p2'substituents |
| 1g49 |  | A carboxylic acid based inhibitor in complex with mmp3 |
| 1g4k |  | X-ray structure of a novel matrix metalloproteinase inhibitor complexed to stromelysin |
| 1g9k |  | Crystal structure of a psychrophilic alkaline protease from pseudomonas tac ii 18 |
| 1gkc |  | Mmp9-inhibitor complex |
| 1gkd |  | Mmp9 active site mutant-inhibitor complex |
| 1go7 |  | The metzincin's methionine: prtc m226c-e189k double mutant |
| 1go8 |  | The metzincin's methionine: prtc m226l mutant |
| 1gxd |  | Prommp-2/timp-2 complex |
| 1h71 |  | Psychrophilic protease from pseudoalteromonas 'tac ii 18' |
| 1hfc |  | 1.56 angstrom structure of mature truncated human fibroblast collagenase |
| 1hfs |  | Crystal structure of the catalytic domain of human fibroblast stromelysin-1 inhibited with the n-carboxy- alkyl inhibitor l-764,004 |
| 1hov |  | Solution structure of a catalytic domain of mmp-2 complexed with sc-74020 |
| 1hv5 |  | Crystal structure of the stromelysin-3 (mmp-11) catalytic domain complexed with a phosphinic inhibitor |
| 1hy7 |  | A carboxylic acid based inhibitor in complex with mmp3 |
| 1i73 |  | Complex of pro-leu-l-trp phosphonate with the catalitic domain of matrix metallo proteinase-8 (met80 form) |
| 1i76 |  | Complex of 2-(biphenyl-4-sulfonyl)-1,2,3,4-tetrahydro- isoquinoline-3-carboxylic acid (d-tic derivative) with t catalitic domain of matrix metallo proteinase-8 (met80 form) |
| 1iaa |  | Crystal structures, spectroscopic features, and catalytic properties of cobalt(ii), copper(ii), nickel(ii), and mercury(ii) derivatives of the zinc endopeptidase astacin. a correlation of structure and proteolytic activity |
| 1iab |  | Crystal structures, spectroscopic features, and catalytic properties of cobalt(ii), copper(ii), nickel(ii), and mercury(ii) derivatives of the zinc endopeptidase astacin. a correlation of structure and proteolytic activity |
| 1iac |  | Refined 1.8 angstroms x-ray crystal structure of astacin, a zinc-endopeptidase from the crayfish astacus astacus l. structure determination, refinement, molecular structure and comparison with thermolysin |
| 1iad |  | Refined 1.8 angstroms x-ray crystal structure of astacin, a zinc-endopeptidase from the crayfish astacus astacus l. structure determination, refinement, molecular structure and comparison to thermolysin |
| 1iae |  | Crystal structures, spectroscopic features, and catalytic properties of cobalt(ii), copper(ii), nickel(ii), and mercury(ii) derivatives of the zinc endopeptidase astacin. a correlation of structure and proteolytic activity |
| 1jan |  | Complex of pro-leu-gly-hydroxylamine with the catalytic domain of matrix metallo proteinase-8 (phe79 form) |
| 1jao |  | Complex of 3-mercapto-2-benzylpropanoyl-ala-gly-nh2 with the catalytic domain of matrix metallo proteinase-8 (met80 form) |
| 1jap |  | Complex of pro-leu-gly-hydroxylamine with the catalytic domain of matrix metallo proteinase-8 (met80 form) |
| 1jaq |  | Complex of 1-hydroxylamine-2-isobutylmalonyl-ala-gly-nh2 with the catalytic domain of matrix metallo proteinase-8 (met80 form) |
| 1jh1 |  | Crystal structure of mmp-8 complexed with a 6h-1,3,4- thiadiazine derived inhibitor |
| 1jiw |  | Crystal structure of the apr-aprin complex |
| 1jiz |  | Crystal structure analysis of human macrophage elastase mmp- |
| 1jj9 |  | Crystal structure of mmp8-barbiturate complex reveals mechanism for collagen substrate recognition |
| 1jk3 |  | Crystal structure of human mmp-12 (macrophage elastase) at true atomic resolution |
| 1k7g |  | Prtc from erwinia chrysanthemi |
| 1k7i |  | Prtc from erwinia chrysanthemi: y228f mutant |
| 1k7q |  | Prtc from erwinia chrysanthemi: e189a mutant |
| 1kap |  | Three-dimensional structure of the alkaline protease of pseudomonas aeruginosa: a two-domain protein with a calcium binding parallel beta roll motif |
| 1kbc |  | Procarboxypeptidase ternary complex |
| 1l6j |  | Crystal structure of human matrix metalloproteinase mmp9 (gelatinase b). |
| 1mmb |  | Complex of bb94 with the catalytic domain of matrix metalloproteinase-8 |
| 1mmp |  | Matrilysin complexed with carboxylate inhibitor |
| 1mmq |  | Matrilysin complexed with hydroxamate inhibitor |
| 1mmr |  | Matrilysin complexed with sulfodiimine inhibitor |
| 1mnc |  | Structure of human neutrophil collagenase reveals large s1' specificity pocket |
| 1o0q |  | Crystal structure of a cold adapted alkaline protease from pseudomonas tac ii 18, co-crystallized with 1 mm edta |
| 1o0t |  | Crystal structure of a cold adapted alkaline protease from pseudomonas tac ii 18, co-crystallized with 5 mm edta (5 days) |
| 1om6 |  | Crystal structure of a cold adapted alkaline protease from pseudomonas tac ii 18, co-crystallized with 5mm edta (2 months) |
| 1om7 |  | Crystal structure of a cold adapted alkaline protease from pseudomonas tac ii 18, soaked in 85 mm edta |
| 1om8 |  | Crystal structure of a cold adapted alkaline protease from pseudomonas tac ii 18, co-crystallyzed with 10 mm edta |
| 1omj |  | Crystal structure of a psychrophilic alkaline protease from pseudomonas tac ii 18 |
| 1oo9 |  | Orientation in solution of mmp-3 catalytic domain and n- timp-1 from residual dipolar couplings |
| 1os2 |  | Ternary enzyme-product-inhibitor complexes of human mmp12 |
| 1os9 |  | Binary enzyme-product complexes of human mmp12 |
| 1q3a |  | Crystal structure of the catalytic domain of human matrix metalloproteinase 10 |
| 1qia |  | Crystal structure of stromelysin catalytic domain |
| 1qib |  | Crystal structure of gelatinase a catalytic domain |
| 1qic |  | Crystal structure of stromelysin catalytic domain |
| 1qji |  | Structure of astacin with a transition-state analogue inhibitor |
| 1qjj |  | Structure of astacin with a hydroxamic acid inhibitor |
| 1rm8 |  | Crystal structure of the catalytic domain of mmp-16/mt3- mmp: characterization of mt-mmp specific features |
| 1rmz |  | Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor nngh at 1.3 a resolution |
| 1ros |  | Crystal structure of mmp-12 complexed to 2-(1,3-dioxo-1,3- dihydro-2h-isoindol-2-yl)ethyl-4-(4-ethoxy[1,1-biphenyl]-4- yl)-4-oxobutanoic acid |
| 1sat |  | Crystal structure of the 50 kda metallo protease from s. marcescens |
| 1slm |  | Crystal structure of fibroblast stromelysin-1: the c- truncated human proenzyme |
| 1sln |  | Crystal structure of the catalytic domain of human fibroblast stromelysin-1 inhibited with the n-carboxy- alkyl inhibitor l-702,842 |
| 1smp |  | Crystal structure of a complex between serratia marcescens metallo-protease and an inhibitor from erwinia chrysanthemi |
| 1srp |  | Structural analysis of serratia protease |
| 1su3 |  | X-ray structure of human prommp-1: new insights into collagenase action |
| 1uea |  | Mmp-3/timp-1 complex |
| 1ums |  | Stromelysin-1 catalytic domain with hydrophobic inhibitor bound, ph 7.0, 32oc, 20 mm cacl2, 15% acetonitrile; nmr ensemble of 20 structures |
| 1umt |  | Stromelysin-1 catalytic domain with hydrophobic inhibitor bound, ph 7.0, 32oc, 20 mm cacl2, 15% acetonitrile; nmr average of 20 structures minimized with restraints |
| 1usn |  | Crystal structure of the catalytic domain of human fibroblast stromelysin-1 inhibited with thiadiazole inhibitor pnu-142372 |
| 1utt |  | Crystal structure of mmp-12 complexed to 2- (1,3-dioxo-1,3-dihydro-2h-isoindol-2-yl)ethyl-4- (4-ethoxy[1,1-biphenyl]-4-yl)-4-oxobutanoic acid |
| 1utz |  | Crystal structure of mmp-12 complexed to (2r)-3-({[4-[(pyri din-4-yl)phenyl]-thien-2-yl}carboxamido)(phenyl)propanoic acid |
| 1xuc |  | Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor |
| 1xud |  | Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor |
| 1xur |  | Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor |
| 1y93 |  | Crystal structure of the catalytic domain of human mmp12 complexed with acetohydroxamic acid at atomic resolution |
| 1ycm |  | Solution structure of matrix metalloproteinase 12 (mmp12) in the presence of n-isobutyl-n-[4- methoxyphenylsulfonyl]glycyl hydroxamic acid (nngh) |
| 1you |  | Crystal structure of the catalytic domain of mmp-13 complexed with a potent pyrimidinetrione inhibitor |
| 1z3j |  | Solution structure of mmp12 in the presence of n-isobutyl-n- 4-methoxyphenylsulfonyl]glycyl hydroxamic acid (nngh) |
| 1zp5 |  | Crystal structure of the complex between mmp-8 and a n- hydroxyurea inhibitor |
| 1zs0 |  | Crystal structure of the complex between mmp-8 and a phosphonate inhibitor (s-enantiomer) |
| 1ztq |  | Crystal structure of the catalytic domain of mmp-13 complexed with way-033 |
| 1zvx |  | Crystal structure of the complex between mmp-8 and a phosphonate inhibitor (r-enantiomer) |
| 2ayk |  | Inhibitor-free catalytic fragment of human fibroblast collagenase, nmr, minimized average structure |
| 2clt |  | Crystal structure of the active form (full-length) of human fibroblast collagenase. |
| 2d1n |  | Collagenase-3 (mmp-13) complexed to a hydroxamic acid inhibitor |
| 2d1o |  | Stromelysin-1 (mmp-3) complexed to a hydroxamic acid inhibitor |
| 2ddy |  | Solution structure of matrilysin (mmp-7) complexed to constraint conformational sulfonamide inhibitor |
| 2e2d |  | Flexibility and variability of timp binding: x-ray structure of the complex between collagenase-3/mmp-13 and timp-2 |
| 2hu6 |  | Crystal structure of human mmp-12 in complex with acetohydroxamic acid and a bicyclic inhibitor |
| 2j0t |  | Crystal structure of the catalytic domain of mmp-1 in complex with the inhibitory domain of timp-1 |
| 2jnp |  | Solution structure of matrix metalloproteinase 3 (mmp-3) in the presence of n-isobutyl-n-[4- methoxyphenylsulfonyl]glycyl hydroxamic acid (nngh) |
| 2jsd |  | Solution structure of mmp20 complexed with nngh |
| 2jt5 |  | Solution structure of matrix metalloproteinase 3 (mmp-3) in the presence of n-hydroxy-2-[n-(2-hydroxyethyl)biphenyl-4- sulfonamide] hydroxamic acid (mlc88) |
| 2jt6 |  | Solution structure of matrix metalloproteinase 3 (mmp-3) in the presence of 3-4'-cyanobyphenyl-4-yloxy)-n- hdydroxypropionamide (mmp-3 inhibitor vii) |
| 2k2g |  | Solution structure of the wild-type catalytic domain of human matrix metalloproteinase 12 (mmp-12) in complex with a tight-binding inhibitor |
| 2k9c |  | Paramagnetic shifts in solid-state nmr of proteins to elicit structural information |
| 2ovx |  | Mmp-9 active site mutant with barbiturate inhibitor |
| 2ovz |  | Mmp-9 active site mutant with phosphinate inhibitor |
| 2ow0 |  | Mmp-9 active site mutant with iodine-labeled carboxylate inhibitor |
| 2ow1 |  | Mmp-9 active site mutant with trifluoromethyl hydroxamate inhibitor |
| 2ow2 |  | Mmp-9 active site mutant with difluoro butanoic acid inhibitor |
| 2ow9 |  | Crystal structure analysis of the mmp13 catalytic domain in complex with specific inhibitor |
| 2oxu |  | Uninhibited form of human mmp-12 |
| 2oxw |  | Human mmp-12 complexed with the peptide iag |
| 2oxz |  | Human mmp-12 in complex with two peptides pqg and iag |
| 2oy2 |  | Human mmp-8 in complex with peptide iag |
| 2oy4 |  | Uninhibited human mmp-8 |
| 2ozr |  | Mmp13 catalytic domain complexed with 4-{[1-methyl-2,4- dioxo-6-(3-phenylprop-1-yn-1-yl)-1,4-dihydroquinazolin- 3(2h)-yl]methyl}benzoic acid |
| 2pjt |  | Crystal structure of the catalytic domain of mmp-13 complexed with way-344 |
| 2poj |  | Nmr solution structure of the inhibitor-free state of macrophage metalloelastase (mmp-12) |
| 2srt |  | Catalytic domain of human stromelysin-1 at ph 5.5 and 40oc complexed with inhibitor |
| 2tcl |  | Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor |
| 2usn |  | Crystal structure of the catalytic domain of human fibroblast stromelysin-1 inhibited with thiadiazole inhibitor pnu-141803 |
| 2w0d |  | Does a fast nuclear magnetic resonance spectroscopy- and x-ray crystallography hybrid approach provide reliable structural information of ligand-protein complexes? a case study of metalloproteinases. |
| 2wo8 |  | Mmp12 complex with a beta hydroxy carboxylic acid |
| 2wo9 |  | Mmp12 complex with a beta hydroxy carboxylic acid |
| 2woa |  | Mmp12 complex with a beta hydroxy carboxylic acid |
| 2z2d |  | Solution structure of human macrophage elastase (mmp-12) catalytic domain complexed with a gamma-keto butanoic acid inhibitor |
| 3ayk |  | Catalytic fragment of human fibroblast collagenase complexed with cgs-27023a, nmr, minimized average structure |
| 3ba0 |  | Crystal structure of full-length human mmp-12 |
| 3dng |  | Crystal structure of the complex between mmp-8 and a non- zinc chelating inhibitor |
| 3dpe |  | Crystal structure of the complex between mmp-8 and a non- zinc chelating inhibitor |
| 3dpf |  | Crystal structure of the complex between mmp-8 and a non- zinc chelating inhibitor |
| 3edg |  | Crystal structure of bone morphogenetic protein 1 protease domain |
| 3edh |  | Crystal structure of bone morphogenetic protein 1 protease domain in complex with partially bound dmso |
| 3edi |  | Crystal structure of tolloid-like protease 1 (tll-1) protease domain |
| 3ehx |  | Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor (r)-2-(biphenyl-4- ylsulfonamido)-4-methylpentanoic acid |
| 3ehy |  | Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor (r)-2-(4- methoxyphenylsulfonamido)propanoic acid |
| 3elm |  | Crystal structure of mmp-13 complexed with inhibitor 24f |
| 3f15 |  | Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor (s)-n-(2,3-dihydroxypropyl)-4- methoxy-n-(2-nitroso-2-oxoethyl)benzenesulfonamide |
| 3f16 |  | Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor (r)-n-(3-hydroxy-1-nitroso-1- oxopropan-2-yl)-4-methoxybenzenesulfonamide |
| 3f17 |  | Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor n-(2-nitroso-2-oxoethyl) biphenyl-4-sulfonamide |
| 3f18 |  | Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor 4-fluoro-n-(2-hydroxyethyl)-n- (2-nitroso-2-oxoethyl)benzenesulfonamide |
| 3f19 |  | Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor 4-fluoro-n-(2-nitroso-2- oxoethyl)benzenesulfonamide |
| 3f1a |  | Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor n-(2-nitroso-2-oxoethyl) benzenesulfonamide |
| 3hb2 |  | Prtc methionine mutants: m226i |
| 3hbu |  | Prtc methionine mutants: m226h desy |
| 3hbv |  | Prtc methionine mutants: m226a in-house |
| 3hda |  | Prtc methionine mutants: m226a_desy |
| 3i7g |  | Mmp-13 in complex with a non zinc-chelating inhibitor |
| 3i7i |  | Mmp-13 in complex with a non zinc-chelating inhibitor |
| 3usn |  | Structure of the catalytic domain of human fibroblast stromelysin-1 inhibited with the thiadiazole inhibitor ipnu-107859, nmr, 1 structure |
| 456c |  | Crystal structure of collagenase-3 (mmp-13) complexed to a diphenyl-ether sulphone based hydroxamic acid |
| 4ayk |  | Catalytic fragment of human fibroblast collagenase complexed with cgs-27023a, nmr, 30 structures |
| 830c |  | Collagenase-3 (mmp-13) complexed to a sulphone-based hydroxamic acid |
| 966c |  | Crystal structure of fibroblast collagenase-1 complexed to a diphenyl-ether sulphone based hydroxamic acid |